Tissue regeneration from transplanted mesenchymal stromal cells (MSC) either through
transdifferentiation or cell fusion was originally proposed as the principal mechanism …

Acute kidney injury (AKI) is the leading cause of nephrology consultation and is associated
with high mortality rates. The primary causes of AKI include ischemia, hypoxia or …

Background Bio-products from stem/progenitor cells, such as extracellular vesicles, are
likely a new promising approach for reprogramming resident cells in both acute and chronic …

Cisplatin is an antitumor drug used in the treatment of a wide variety of malignancies.
However, its primary dose‐limiting side effect is kidney injury, which is a major clinical …

Introduction Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …

End-stage organ failure is a key challenge for the medical community because of the ageing
population and the severe shortage of suitable donor organs available. Equally, injuries to …

Mesenchymal stem/stromal cells (MSCs) can regenerate tissues by direct differentiation or
indirectly by stimulating angiogenesis, limiting inflammation, and recruiting tissue-specific …

Mesenchymal stem cells (MSCs) are multipotent adult stem cells present in all tissues, as
part of the perivascular population. As multipotent cells, MSCs can differentiate into different …

Abstract Three‐dimensional (3D) cell culture has been reported to increase the therapeutic
potentials of mesenchymal stem cells (MSC s). In this study, we aimed to investigate the …

Independent studies by numerous investigators have shown that it is possible to harvest
multipotent progenitor cells from diverse dissociated and cultured fetal, perinatal, and …